JP2023520590A5 - - Google Patents

Info

Publication number
JP2023520590A5
JP2023520590A5 JP2022560915A JP2022560915A JP2023520590A5 JP 2023520590 A5 JP2023520590 A5 JP 2023520590A5 JP 2022560915 A JP2022560915 A JP 2022560915A JP 2022560915 A JP2022560915 A JP 2022560915A JP 2023520590 A5 JP2023520590 A5 JP 2023520590A5
Authority
JP
Japan
Application number
JP2022560915A
Other languages
Japanese (ja)
Other versions
JP7801240B2 (ja
JP2023520590A (ja
JPWO2021207091A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/025806 external-priority patent/WO2021207091A1/en
Publication of JP2023520590A publication Critical patent/JP2023520590A/ja
Publication of JP2023520590A5 publication Critical patent/JP2023520590A5/ja
Publication of JPWO2021207091A5 publication Critical patent/JPWO2021207091A5/ja
Application granted granted Critical
Publication of JP7801240B2 publication Critical patent/JP7801240B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022560915A 2020-04-06 2021-04-05 病原体診断検査 Active JP7801240B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202063005996P 2020-04-06 2020-04-06
US63/005,996 2020-04-06
US202063062406P 2020-08-06 2020-08-06
US63/062,406 2020-08-06
US202163136449P 2021-01-12 2021-01-12
US63/136,449 2021-01-12
US202163154571P 2021-02-26 2021-02-26
US63/154,571 2021-02-26
PCT/US2021/025806 WO2021207091A1 (en) 2020-04-06 2021-04-05 Pathogen diagnostic test

Publications (4)

Publication Number Publication Date
JP2023520590A JP2023520590A (ja) 2023-05-17
JP2023520590A5 true JP2023520590A5 (https=) 2024-04-10
JPWO2021207091A5 JPWO2021207091A5 (https=) 2024-04-10
JP7801240B2 JP7801240B2 (ja) 2026-01-16

Family

ID=75675001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022560915A Active JP7801240B2 (ja) 2020-04-06 2021-04-05 病原体診断検査

Country Status (11)

Country Link
US (2) US12129523B2 (https=)
EP (2) EP4286538A3 (https=)
JP (1) JP7801240B2 (https=)
KR (1) KR20220164745A (https=)
CN (1) CN115917002A (https=)
AU (1) AU2021251703A1 (https=)
BR (1) BR112022020143A2 (https=)
CA (1) CA3179579A1 (https=)
IL (1) IL297033A (https=)
MX (1) MX2022012516A (https=)
WO (1) WO2021207091A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230019965A (ko) * 2020-06-22 2023-02-09 주식회사 씨젠 검체 내 타겟 핵산 서열 검출을 위한 준비물을 제공하는 방법
CN118696132A (zh) * 2021-12-22 2024-09-24 奥科坦特公司 用于报道基因筛选测定的质量控制
US12553093B1 (en) * 2025-03-26 2026-02-17 Wolf of Zion, Inc. Methods of detecting, identifying and quantifying wild spike protein and covid vaccine spike proteins

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582740B2 (en) * 2003-04-17 2009-09-01 The Trustees Of Columbia University In The City Of New York Methods and kits for detecting SARS-associated coronavirus
EP1957678B1 (en) * 2005-11-28 2012-06-13 Ibis Biosciences, Inc. Compositions for use in identification of adventitious contaminant viruses
CN101384730A (zh) * 2005-12-23 2009-03-11 阿尔维德医药技术公司 用于传染病和癌症检测的分子信标成像的方法和应用
US8354230B2 (en) 2007-12-21 2013-01-15 Quest Diagnostics Investments Inc. Multiplex detection assay for influenza and RSV viruses
EP2913402B1 (en) 2010-07-16 2017-10-18 Tocagen Inc. Retrovirus detection
BR112014000138B1 (pt) 2011-07-06 2021-11-16 Quest Diagnostics Investments Incorporation Método para identificar a presença ou ausência de um ácido nucleico alvo
WO2016057749A1 (en) 2014-10-08 2016-04-14 Theranos, Inc. Methods and devices for real-time diagnostic testing (rdt) for ebola and other infectious diseases
CN107922971A (zh) * 2015-05-18 2018-04-17 凯锐思公司 用于富集核酸群体的组合物和方法
JP2017209036A (ja) 2016-05-24 2017-11-30 東洋紡株式会社 改良されたウイルス検出方法
JP7167913B2 (ja) 2017-04-26 2022-11-09 東洋紡株式会社 ウイルスの検査方法およびウイルスの検査用キット
CA3166337A1 (en) * 2020-03-09 2021-09-16 F. Hoffmann-La Roche Ag Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (sars-cov-2), influenza a and influenza b
CN111494616A (zh) * 2020-04-27 2020-08-07 重庆医科大学附属永川医院 一种新冠病毒免疫增强型基因疫苗及其制备方法

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
JP2023520590A5 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)